HYPERHOMOCYSTEINEMIA IS A MARKER AND MEDIATOR OF NASH: DISCOVERY OF A NOVEL VITAMIN THERAPY (B12 AND FOLATE) FOR NASH
Publication
, Conference
Tripathi, M; Singh, BK; Zhou, J; Tikno, K; Widjaja, AA; Sandireddy, R; Suzuki, A; Xiao, R-P; Zhang, X; Chow, P; Yen, PM
Published in: HEPATOLOGY
2020
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
52A / 52A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Tripathi, M., Singh, B. K., Zhou, J., Tikno, K., Widjaja, A. A., Sandireddy, R., … Yen, P. M. (2020). HYPERHOMOCYSTEINEMIA IS A MARKER AND MEDIATOR OF NASH: DISCOVERY OF A NOVEL VITAMIN THERAPY (B12 AND FOLATE) FOR NASH. In HEPATOLOGY (Vol. 72, pp. 52A-52A).
Tripathi, Madhulika, Bnjesh Kumar Singh, Jin Zhou, Keziah Tikno, Anissa Anindya Widjaja, Reddemma Sandireddy, Ayako Suzuki, et al. “HYPERHOMOCYSTEINEMIA IS A MARKER AND MEDIATOR OF NASH: DISCOVERY OF A NOVEL VITAMIN THERAPY (B12 AND FOLATE) FOR NASH.” In HEPATOLOGY, 72:52A-52A, 2020.
Tripathi M, Singh BK, Zhou J, Tikno K, Widjaja AA, Sandireddy R, et al. HYPERHOMOCYSTEINEMIA IS A MARKER AND MEDIATOR OF NASH: DISCOVERY OF A NOVEL VITAMIN THERAPY (B12 AND FOLATE) FOR NASH. In: HEPATOLOGY. 2020. p. 52A-52A.
Tripathi, Madhulika, et al. “HYPERHOMOCYSTEINEMIA IS A MARKER AND MEDIATOR OF NASH: DISCOVERY OF A NOVEL VITAMIN THERAPY (B12 AND FOLATE) FOR NASH.” HEPATOLOGY, vol. 72, 2020, pp. 52A-52A.
Tripathi M, Singh BK, Zhou J, Tikno K, Widjaja AA, Sandireddy R, Suzuki A, Xiao R-P, Zhang X, Chow P, Yen PM. HYPERHOMOCYSTEINEMIA IS A MARKER AND MEDIATOR OF NASH: DISCOVERY OF A NOVEL VITAMIN THERAPY (B12 AND FOLATE) FOR NASH. HEPATOLOGY. 2020. p. 52A-52A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
2020
Volume
72
Start / End Page
52A / 52A
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics